News By Tag
News By Location
1 week to go to SMi's 22nd Annual Superbugs & Superdrugs Conference
SMi Reports: Superbugs & Superdrugs conference taking place next week, will now be by remote access only
By: SMi Group
Interested parties are urged to register at: www.superbugssuperdrugs.com/
The conference will consist of an impressive 15+ speaker line-up from well-established big pharma, academia and government organisations, where delegates can hear their extensive experiences and knowledge on the critical subject of growing antibiotic resistance.
The two-day conference is co-chaired by Cara Cassino, CMO, Contrafect and Michael Dawson, Director, Mike Dawson Antimicrobial Research Consultancy.
Featured 2020 Experts and Remote Presentations:
Exploring new classes of non-antibiotic antibacterial proteins: Colicins and Colicin-like Bacteriocins
Yuri Gleba, Professor, Founder, Nomad Bioscience
Update on the UK project looking at novel value assessment and reimbursement for novel antimicrobials
Colm Leonard, Consultant Clinical Adviser/Consultant Thoracic Physician/Honorary Professor of Medicine, NICE & Machester University NHS Foundation Trust
The BARDA Antibacterials Program
Brian Tse, Health Scientist, Biomedical Advanced Research and Development Authority (BARDA)
Discovery of Dabocins, a novel class of non-ß-lactam PBP inhibitors
Francois Moreau, Scientific Director, Mutabilis S A
Evaluating the utility of machine learning and AI in antibiotic drug discovery
Paul Finn, CEO, Oxford Drug Design
The conference with remote access is available for registration for only £999. Register at www.superbugssuperdrugs.com/
The event is sponsored by Scynexis.
For sponsorship enquiries, contact Alia Malick on +44 (0)20 7827 6164 or amalick@smi-
For registration information, contact Dylan Brohm at firstname.lastname@example.org or call on +44 (0) 207 827 1024.
For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or email@example.com
Superbugs & Superdrugs 2020
Conference: 30th – 31st March 2020
Remote Access Only